Total intravenous anaesthesia (TIVA) in combination with venturi jet ventilation has been used for microlaryngeal surgery involving vocal cord and other procedures in the upper airway for many years [1] [2] [3] [4] [5] . Continuous infusion or intermittent injection of various ultra-short-acting intravenous anaesthetics (e.g. thiopentone, methohexitone, etomidate, althesin and propofol) have been successfully used for years [1] [2] [3] [4] [5] [6] [7] . A number of complex dose regimens and infusion schemes have been devised in order to keep the blood concentration at the desired level, but it is still difficult to provide adequate anaesthesia to cope with individual variation in responses to surgical stimuli. Light anaesthesia with sweating, lacrimation, tachycardia, hypertension and dysrhythmia was frequently observed.
Flumazenil (Anexate R ), a specific benzodiazepine antagonist, has been introduced to treat benzodiazepine over-sedation and intoxication [8] [9] [10] . Availability of flumazenil allows a benzodiazepine of appropriate duration of action to be used as the main drug in TIVA 1, [11] [12] . The benzodiazepine anaesthesia can be reversed at the end of the procedure. This may help make the technique of TIVA simple and easy.
In order to find an alternative to a complicated infusion scheme, we studied the quality of TIVA using single-dose midazolam, topical anaesthesia and muscle relaxants for microlaryngoscopic procedures, and evaluated the quality of recovery when flumazenil was used or not used to reverse the effect of midazolam anaesthesia.
MATERIALS AND METHODS
The study was double-blind, parallel, and was approved by the author's institutional ethics committee on human study. Forty consecutive and consenting patients, aged between 12 and 60 years, ASA class 1-2 undergoing elective microlaryngoscopy± bronchoscopy under general anaesthesia using midazolam and jet ventilation were studied. They were randomly allocated to receive either flumazenil or 
SUMMARY
A comparison between midazolam and midazolam-flumazenil for total intravenous anaesthesia in combination with topical anaesthesia and muscle relaxants was performed in a double-blind, parallel study in 40 patients scheduled for microlaryngoscopy with or without bronchoscopic procedures using jet ventilation with oxygen. A single intravenous injection of midazolam 0.3 mg/kg, lignocaine spray and muscle relaxants provided adequate anaesthesia and good operative conditions throughout the procedures, which took 20 to 30 minutes.
Patients who had placebo at the end of the procedures had a longer recovery and a high incidence of airway obstruction (20%). Administration of flumazenil provided prompt awakening in 19 of 20 patients (95%) within five minutes, resulting in rapid and favourable recovery without resedation or other side-effects, while only three of 20 (15%) patients in the placebo-treated group had improved consciousness within five minutes.
The simplicity and reliability of the midazolam-flumazenil technique is attractive. We consider it worthy of further investigation for wider application in clinical practice.
placebo to reverse the effect of midazolam. Patients who were unwilling to participate had clinical signs of upper airway obstruction, or physical status beyond ASA class 2 were excluded from the study.
Patients were premedicated with 0.4-0.6 mg atropine sulphate subcutaneously 30 to 45 minutes before induction of anaesthesia. Midazolam 0.3 mg/kg was given intravenously. After disappearance of the eyelid reflex, succinylcholine 1 to 1.5 mg/kg was given IV. Following manual ventilation with oxygen via a mask until the completion of muscle fasciculation, a laryngoscope blade was inserted and five to ten puffs of 10% lignocaine were sprayed on the mucosa at the base of tongue, posterior pharyngeal wall, epiglottis and larynx. In the case of bronchoscopy, lignocaine was also sprayed into the trachea.
Manual ventilation with oxygen was carried out for one to two minutes to allow the topical anaesthetic to take effect. A microlaryngeal tube (Thara tube, a reinforced polyethylene tube with 3.5 mm external and 2.16 mm internal diameter) 13 , was introduced and the patient was ventilated with manual control lowfrequency (10 to 14 minute) high-flow venturi oxygen jet ventilation. After ensuring good air entry and exit from both lungs, surgeons were allowed to perform the laryngoscopic and/or bronchoscopic procedures. Muscle relaxation was maintained by either intravenous atracurium 0.5 mg/kg for a procedure expecting to last longer than twenty minutes, or intermittent succinylcholine (0.5-1 mg/kg) for a shorter procedure. Anaesthesia was maintained by the single dose of intravenous midazolam given at induction of anaesthesia. No other anaesthetic or opioid was given.
At the end of the procedure, the effect of the nondepolarizing muscle relaxant was reversed. When succinylcholine was used, ventilation was supported until adequate spontaneous respiration resumed, then the microlaryngeal tube was removed. Five minutes after extubation, either flumazenil or placebo was injected in a randomized double-blind fashion. From a coded ampoule of 10 ml containing either 0.1 mg/ml flumazenil or placebo of identical physical appearance, 2 ml was first injected in 15 seconds: if there was no marked change in the level of consciousness, a second dose of 2 ml was injected 60 seconds later. The injection was repeated as necessary every 60 seconds until an observable improvement of consciousness was achieved or up to a total dose of 10 ml. The codes were kept secret in sealed envelopes and revealed for data analysis after the completion of the collection of data.
The operative conditions were subjectively evaluated by the anaesthetist as:
(a) adequate when there were no signs of light anaesthesia, i.e. sweating, lacrimation, dysrhythmia; (b) inadequate when there was sweating, lacrimation and dysrhythmia; and (c) poor when all or some of these occurred to a degree that disturbed the surgical procedure. In the postoperative period, patients were evaluated for degree of sedation, response to command and orientation before and 5, 15, 30, 60, and 120 minutes after the injection of flumazenil or placebo. The degree of sedation was graded on a 0 to 4 point scale (patient awake and alert=4; awake and calm=3; drowsy=2; asleep but rousable 1; asleep not rousable=0). Co-operation and response to command were evaluated by simple tests such as obeying of an order to raise one hand, or distend the cheeks and was graded 0 to 2 points (obeying of verbal com-mand=2; obeying of the order by imitation=1; no response to the order=0). Orientation in time and space was graded 2 when both were present; 1 when partial orientation was present and zero when none or total disorientation was present. The patients were observed in the recovery room for at least two hours before being sent to the regular ward.
In the 24 hours postoperatively, physician assessment of the patient's consciousness, mood, respiration, severity of pain, cough reflex, nausea or vomiting and any possible adverse reactions were noted. In the morning following the procedure, the patients were asked whether they could recall any event in the operating room or in the recovery room.
For statistical analysis, Student's t test was used for comparing demographic data, duration of anaesthesia and operation; Mann-Whitney U-test for nonparametric data; analysis of variance and least significant difference (LSD) procedure for vital signs and Chi-square test for comparing the effect of flumazenil and placebo. P value of less than 0.05 was considered to have statistical significance.
RESULTS
Groups did not differ in terms of age, weight, sex, duration of anaesthesia or operation (Table 1) . Following induction of anaesthesia with intravenous midazolam, blood pressure and heart rate were not significantly changed but significantly increased (20-30%) following intubation and remained higher than the pre-induction level throughout the operative procedures and returned to the pre-induction level five to ten minutes after extubation ( Figure 1 ). Administration of flumazenil did not cause any significant change in these parameters.
The overall operative condition was assessed as adequate in all patients. No patient showed signs of light anaesthesia, i.e. sweating, lacrimation or dysrhythmia. Anaesthesia was stable and remained at a rather deep level throughout the procedure.
After the completion of the procedure and five minutes following the reversal of muscle relaxant and extubation but before injection of flumazenil or placebo, 38 out of 40 patients were still heavily sedated, and were slightly rousable but unable to perform tests or to answer any questions.
After injection of flumazenil, there was a dramatic improvement of level of consciousness in 19 out of 20 (95%) patients. They became rousable in one to two minutes ( Figure 2 ). They were able to respond to verbal command and perform tests, and became oriented in time and space within three to four minutes. In the recovery room, most of them were awake, calm and relaxed. While unstimulated, they were sleepy but able to give a prompt response to verbal stimulation. There was not much change in the level of consciousness during 120 minutes' observation in the recovery room, except in one patient who had less response to flumazenil and became rousable after 15 minutes ( Figure 2 ). None of them lapsed into deep sleep or unconsciousness again. There was neither any upper airway problem nor anxiety or agitation in any patient in this group. The mean dose of flumazenil producing significant improvement of consciousness ( Table 2 ) was 0.3±0.17 mg. The whole ampoule of 10 ml of flumazenil was inadvertently given as a bolus by an assistant to a patient resulting in immediate awakening. Another whole ampoule was given in incremental doses to another patient without significant improvement of consciousness.
Five and 15 minutes after injection of placebo, only three out of 20 (15%) patients had significant 360 W. RUSHATAMUKAYANUNT, T. TRITRAKARN Anaesthesia and Intensive Care, Vol. 25, No. 4, August 1997 improvement of consciousness ( Figure 2) . Recovery in the rest was gradual. They were drowsy for another hour and slowly wakened one to two hours later. This conformed to the normal recovery following intravenous administration of midazolam. Four out of 20 patients (20%) in this group had partial airway obstruction in recovery room, requiring re-intubation in three, of which two were uneventfully extubated one hour later and one was found to have severe laryngeal oedema due to extensive surgical manipulation, necessitating a tracheostomy subsequently. Two patients were confused and disorientated in the recovery room. Patients given flumazenil scored significantly better (P<0.001 and P<0.01) than those given placebo on the degree of sedation, response to command at 5 to 30 minutes but the groups were no longer different at 60 and 120 minutes after the completion of the procedures (Figure 3 ). Neither resedation nor anxiety was encountered in any patients.
When the patients were interviewed 24 hours after the procedures, none of them in any group could recall any event in the operating room or recovery room.
The incidence of nausea and vomiting was low in both groups. Only one patient in the placebo group vomited. One patient in the flumazenil group had nausea and retching but no vomiting.
No adverse reaction or side-effect following injection of flumazenil or placebo was noted. One patient had a short episode of myoclonus immediately following injection of midazolam. He had neither history of epilepsy nor convulsive disorder. His subsequent course of anaesthesia was smooth and uneventful. He had no recall of any event in the operating room.
In the 24 hour postoperative course, patients in both groups were calm, relaxed and had normal respiration and cough reflex. No other adverse reaction attributable to either midazolam, flumazenil or placebo was noted.
DISCUSSION
Microlaryngoscopic procedures under general anaesthesia and jet ventilation require a deep level of anaesthesia with a smooth induction, prompt awakening, and rapid recovery of cough reflex to prevent possible aspiration of blood and debris 2,6,12 . It is difficult to cope with the variation in surgical stimuli and the individual patient's response which alter anaesthetic needs, even with various complex dose regimens and infusion schemes of short-acting intravenous anaesthetics (propofol, thiopentone, methohexitone, etomidate and althesin) [1] [2] [3] [4] [5] [6] [7] . These dose regimens were designed to keep blood concentration at the desired level and need further clinical adjustment during the procedures. Patients were often kept in light anaesthesia to ensure prompt awakening after discontinuation of infusion of drugs. Episodes of light anaesthesia with sweating, lacrimation, tachycardia, hypertension and dysrhythmia occurred frequently [6] [7] .
Midazolam has been widely used as premedication and/or supplement to inhalation anaesthesia 14, 15 but was not satisfactorily used as main agent for TIVA 15, 16 . Too small a dose produced inadequate anaesthesia, while too large a dose caused prolonged recovery. Lack of analgesic property necessitates the combination of potent analgesics or opioids which may lead to prolonged recovery and postoperative respiratory depression and hypoxaemia 16 . The result of our study showed that a single intravenous injection of anaesthetic dose of midazolam (0.3 mg/kg) 15, 17 given for induction of anaesthesia provided adequate anaesthesia and excellent anterograde amnesia for these short procedures of 20 to 30 minutes. Lignocaine 361 MIDAZOLAM-FLUMAZENIL ANAESTHESIA FOR MICROLARYNGOSCOPY Anaesthesia and Intensive Care, Vol. 25, No. 4, August 1997 spray was used to provide topical anaesthesia and to reduce the reaction to laryngoscopy. A muscle relaxant abolished patient movement and facilitated anaesthesia and laryngoscopy. The overall operative condition was subjectively evaluated as adequate in all patients. The delayed recovery with a high incidence of partial upper airway obstruction (20%) requiring airway support and re-intubation in patients the unantagonized group confirmed that midazolam anaesthesia without subsequent reversal was not suitable for use in these short procedures even without opioid supplement.
The use of flumazenil to treat benzodiazepine over-sedation or intoxication has been established 8-10 , but the use in anaesthesia is still controversial. Prompt awakening of patients after flumazenil administration to reverse midazolam anaesthesia can be regarded as an advantage [17] [18] [19] [20] . Short recovery time in which patients are fully awake within one to two minutes, responsive, calm, relaxed and retaining protective reflexes and effective cover are particularly important in patients who have undergone surgical manipulation of the upper airway 12 .
The short half-life is the major disadvantage of flumazenil. If a patient has been over-sedated with an excessive dose of midazolam or a long-acting benzodiazepine, he may become resedated or unconscious again after one to two hours when the effect of flumazenil has worn off 8 . Flumazenil has a shorter half-life (t ½ b=35.3±13.8 min) than midazolam (t ½ b=107± 30 min) 21 . Resedation may occur when additional midazolam is infused after the induction dose or other sedative or opiates are used for maintenance of anaesthesia 1, 11, 17 . The effect of resedation might be over emphasized. The result of multicentre double-blind clinical studies on reversal of the central effect of midazolam by intravenous flumazenil in outpatients when midazolam was used with short-acting opioids (fentanyl or sufentanil) and nitrous oxide showed that 94% of the reversed patients were awake and alert within five minutes compared with 13% in the placebo-treated patients. Alertness after reversal was maintained in 93% throughout the 180 minute observation period 22 . When long-acting opioid was used with midazolam in a similar multicentre doubleblind clinical studies in hospitalized patients, 76% of the flumazenil treated and 18% of the placebo treated were awake and alert within five minutes after reversal. The level of arousal was maintained in 79% of 180 minutes of observation in flumazenil-treated patients 23 . A similar finding was observed when shortacting opioids were used with midazolam in hospitalized patients 24 . The efficacy and safety of flumazenil was not compromised by the addition of short-acting opioid 24 . Patients given flumazenil did not experience more pain at the operative site or require more postoperative analgesic medication than those given placebo [22] [23] [24] . Psychomotor performance, measured by finger-to-nose test, was rated as normal at five minutes post treatment in 77% of flumazenil-treated and 4% of placebo-treated patients 22 . No serious adverse effect of flumazenil was found in these studies. The most frequent adverse effects were nausea, dizziness, vomiting and shivering [22] [23] [24] . Flumazenil does not completely antagonize all the effect of midazolam. There was still significant impairment of objective psychomotor testing up to three hours and residual sedation and memory deficit up to four hours following the reversal of midazolam 19, 20 . Patients should not be discharged unaccompanied or allowed to drive for four hours.
There were few previous reports of using midazolam-flumazenil anaesthesia for ENT endoscopic procedures 1, 12, 25 . Midazolam (0.2 mg/kg IV) was used in 107 rigid bronchoscopic examinations in children ventilated with nitrous oxide and oxygen or oxygen alone with fentanyl. Midazolam provided effective sedation and satisfactory anaesthesia for the procedure. Flumazenil provided prompt awakening with effective cough reflex 12 . Midazolam-flumazenil was compared with propofol in 80 ambulatory ENT endoscopic procedures 25 . It was found that in midazolamflumazenil group, haemodynamic stability was better maintained in poor cardiovascular risk patients and early recovery was faster, whereas street-fitness was more rapidly obtained in the propofol group. Total intravenous anaesthesia with methohexitone (100 mg induction and 10 mg/min infusion) was compared with midazolam anaesthesia (15 mg induction and 0.1 mg/min infusion) for microlaryngeal surgery under jet ventilation 1 . Alfentanil (5 mg) was used to provide analgesia. Both techniques provided appropriate and equivalent anaesthesia with identical haemodynamic responses to the operation and during the postoperative period. Recovery from methohexitone was gradual and patients were in a state of deep sedation up to 45 minutes while reversal of midazolam with flumazenil provided prompt awakening immediately after the injection of the antagonist. Mild resedation was observed in all patients receiving flumazenil within 60 minutes after antagonism with a decrease in oxygen saturation at 45 to 60 minutes 1 .
The results of our study confirmed the quoted previous reports that midazolam (0.3 mg/kg IV) provided adequate deep sedation for these procedures and flumazenil reversal provided prompt awakening in 95% compared with 15% in the placebo treated patients. Hyperdynamic response to laryngoscopy and surgical manipulation of the upper airway was still not well controlled. Blood pressure and heart rate during the operation were significantly raised (20-30%) above the pre-induction value and returned to the control level five to ten minutes after the end of surgery. A single injection of midazolam at induction of anaesthesia was found to be sufficient for procedures of 20 to 30 minutes duration. Midazolam infusion may not be necessary, as evidenced by the level of consciousness of the unantagonized patients who were still in a deeply sedated state in the postoperative period for 15 to 30 minutes. Midazolam infusion may be undesirable when the shorter duration flumazenil is used to antagonize midazolam. The blood level of midazolam is kept at high level by the infusion and wears off more slowly than the antagonistic drug, resulting in a high incidence of resedation and desaturation in the postoperative period. Attenuation of the hyperdynamic response to laryngoscopy and intubation has been a subject of investigation for years. Esmolol and nicardipine were reported to be effective 26 . Combination of midazolam (0.2 mg/kg) and fentanyl (6µg/kg) was reported to abolish the adverse haemodynamic response and modified the associated increase in plasma catecholine concentration with endotracheal intubation 27 , but was not sufficient to attenuate these responses in microlaryngoscopic procedures with surgical manipulation of the upper airway 1, 12, 25 .
The increasing cost of medical care is currently a subject of concern worldwide. Propofol is one of the most common drugs used in TIVA for ENT endoscopic procedures 25 . A procedure of 20 to 30 minutes in an average adult requires two to three ampoules (200 mg in 20 ml) of propofol which cost U.S.$13 each in the authors' country. The procedure costs U.S.$26 to $39. Midazolam-flumazenil technique requires an ampoule of midazolam (15 mg in 3 ml, U.S.$2) and a half ampoule of flumazenil (0.5 mg, U.S.$22) and costs U.S.$13 if an ampoule of flumazenil is used for two patients or $24 if used in only one patient. The midazolam-flumazenil method is economically more favourable than the use of propofol and has the advantage of simplicity of technique.
In conclusion, we found that flumazenil is effective and safe in reversing the effect of midazolam used as main agent in TIVA for microlaryngoscopic and bronchoscopic procedures under jet ventilation with oxygen. A single injection of midazolam at induction of anaesthesia combined with topical analgesia and muscle relaxants provided adequate sedation and satisfactory anaesthesia throughout the procedures. Reversal of midazolam provides favourable recovery with prompt awakening, returning of cough reflex and excellent amnesia. The simplicity and reliability of the technique is an attractive alternative technique to TIVA. It is worth consideration for further investigation for wider application in clinical practice.
